{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:29:39Z","timestamp":1793503779715,"version":"4.5.0"},"reference-count":52,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,31]],"date-time":"2025-01-31T00:00:00Z","timestamp":1738281600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100016374","name":"Cures Within Reach","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.ebiom.2025.105600","type":"journal-article","created":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T12:19:23Z","timestamp":1740658763000},"page":"105600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults"],"prefix":"10.1016","volume":"113","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4856-4334","authenticated-orcid":false,"given":"Michael","family":"Abouyannis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne K.","family":"Nyambura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samson","family":"Ngome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debra","family":"Riako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Musyoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Muiruri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benedict","family":"Orindi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Else","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alieu","family":"Amara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Clare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura-Oana","family":"Albulescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam P.","family":"Westhorpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen","family":"Kool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ifedayo","family":"Adetifa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis M.","family":"Ndungu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saye","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David G.","family":"Lalloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8035-4719","authenticated-orcid":false,"given":"Nicholas R.","family":"Casewell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0266-1414","authenticated-orcid":false,"given":"Mainga","family":"Hamaluba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ebiom.2025.105600_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009589","article-title":"Clinical outcomes and outcome measurement tools reported in randomised controlled trials of treatment for snakebite envenoming: a systematic review","volume":"15","author":"Abouyannis","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib2","article-title":"Snakebite envenoming","volume":"3","author":"Guti\u00e9rrez","year":"2017","journal-title":"Nat Rev Dis Prim"},{"key":"10.1016\/j.ebiom.2025.105600_bib3","doi-asserted-by":"crossref","first-page":"e218","DOI":"10.1371\/journal.pmed.0050218","article-title":"The global burden of snakebite: a literature analysis and modelling based on regional estimates of envenoming and deaths","volume":"5","author":"Kasturiratne","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/j.ebiom.2025.105600_bib4","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1016\/S0041-0101(98)00145-7","article-title":"Neutralization of local tissue damage induced by Bothrops asper (terciopelo) snake venom","volume":"36","author":"Guti\u00e9rrez","year":"1998","journal-title":"Toxicon"},{"key":"10.1016\/j.ebiom.2025.105600_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002326","article-title":"Immune response to snake envenoming and treatment with antivenom; complement activation, cytokine production and mast cell degranulation","volume":"7","author":"Stone","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib6","doi-asserted-by":"crossref","first-page":"e0007551","DOI":"10.1371\/journal.pntd.0007551","article-title":"Reviewing evidence of the clinical effectiveness of commercially available antivenoms in sub-Saharan Africa identifies the need for a multi-centre, multi-antivenom clinical trial","volume":"13","author":"Potet","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0003896","article-title":"Antivenoms for snakebite envenoming: what is in the research pipeline?","volume":"9","author":"Alirol","year":"2015","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib8","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/S0140-6736(18)31224-8","article-title":"Vulnerability to snakebite envenoming: a global mapping of hotspots","volume":"392","author":"Longbottom","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/j.ebiom.2025.105600_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005969","article-title":"Preclinical antivenom-efficacy testing reveals potentially disturbing deficiencies of snakebite treatment capability in East Africa","volume":"11","author":"Harrison","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib10","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0010987","article-title":"A\u00a0long-term observational study of paediatric snakebite in Kilifi County, south-east Kenya","volume":"17","author":"Abouyannis","year":"2023","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib11","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s41182-022-00421-8","article-title":"Snakebite victim profiles and treatment-seeking behaviors in two regions of Kenya: results from a health demographic surveillance system","volume":"50","author":"Larson","year":"2022","journal-title":"Trop Med Health"},{"key":"10.1016\/j.ebiom.2025.105600_bib12","doi-asserted-by":"crossref","first-page":"290","DOI":"10.3390\/toxins9090290","article-title":"A\u00a0review and database of snake venom proteomes","volume":"9","author":"Tasoulis","year":"2017","journal-title":"Toxins"},{"key":"10.1016\/j.ebiom.2025.105600_bib13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1038\/s42003-018-0039-1","article-title":"The paraspecific neutralisation of snake venom induced coagulopathy by antivenoms","volume":"1","author":"Ainsworth","year":"2018","journal-title":"Commun Biol"},{"key":"10.1016\/j.ebiom.2025.105600_bib14","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aay8314","article-title":"Preclinical validation of a repurposed metal chelator as an early-intervention therapeutic for hemotoxic snakebite","volume":"12","author":"Albulescu","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/j.ebiom.2025.105600_bib15","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1146\/annurev.pa.23.040183.001205","article-title":"DMSA and DMPS--water soluble antidotes for heavy metal poisoning","volume":"23","author":"Aposhian","year":"1983","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1016\/j.ebiom.2025.105600_bib18","series-title":"Poisoning & drug overdose","article-title":"Unithiol (DMPS)","author":"Kosnett","year":"2018"},{"key":"10.1016\/j.ebiom.2025.105600_bib19","doi-asserted-by":"crossref","first-page":"23206","DOI":"10.26717\/BJSTR.2020.30.004918","article-title":"DMPS in metal chelation","volume":"30","author":"Blaurock-Busch","year":"2020","journal-title":"BJSTR"},{"key":"10.1016\/j.ebiom.2025.105600_bib20","doi-asserted-by":"crossref","first-page":"7812","DOI":"10.1038\/s41467-023-43510-w","article-title":"Repurposed drugs and their combinations prevent morbidity-inducing dermonecrosis caused by diverse cytotoxic snake venoms","volume":"14","author":"Hall","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105600_bib21","first-page":"603","article-title":"Synthesis and properties of dimercapto derivates of\u00a0alkylsulfonic acids. 1: synthesis of sodium 2, 3-dimercaptopropylsulfonate (unithiol) and sodium 2-mercaptoethylsulfonate","volume":"22","author":"Petrunkin","year":"1956","journal-title":"Ukr Khim Zh (Russ Ed)"},{"key":"10.1016\/j.ebiom.2025.105600_bib22","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S0022-3565(25)12833-4","article-title":"Determination and metabolism of dithiol chelating agents. XVII. In humans, sodium 2,3-dimercapto-1-propanesulfonate is bound to plasma albumin via mixed disulfide formation and is found in the urine as cyclic polymeric disulfides","volume":"277","author":"Maiorino","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ebiom.2025.105600_bib23","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S0022-3565(25)20546-8","article-title":"Determination and metabolism of dithiol chelating agents. XII. Metabolism and pharmacokinetics of sodium 2,3-dimercaptopropane-1-sulfonate in humans","volume":"259","author":"Maiorino","year":"1991","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ebiom.2025.105600_bib24","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/2008-2231-22-46","article-title":"Current approaches of the management of mercury poisoning: need of the hour","volume":"22","author":"Rafati-Rahimzadeh","year":"2014","journal-title":"Daru"},{"key":"10.1016\/j.ebiom.2025.105600_bib25","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12688\/wellcomeopenres.17682.1","article-title":"TRUE-1: trial of Repurposed Unithiol for snakebite Envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)","volume":"7","author":"Abouyannis","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ebiom.2025.105600_bib26","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.socscimed.2008.02.007","article-title":"Beginning community engagement at a busy biomedical research programme: Experiences from the KEMRI CGMRC-Wellcome Trust Research Programme, Kilifi, Kenya","volume":"67","author":"Marsh","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/j.ebiom.2025.105600_bib27","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ije\/dys062","article-title":"Profile: the Kilifi health and demographic surveillance system (KHDSS)","volume":"41","author":"Scott","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/j.ebiom.2025.105600_bib28","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/S0022-3565(25)12952-2","article-title":"Sodium 2,3-dimercaptopropane-1-sulfonate challenge test for mercury in humans. III. Urinary mercury after exposure to mercurous chloride","volume":"277","author":"Maiorino","year":"1996","journal-title":"J\u00a0Pharmacol Exp Ther"},{"key":"10.1016\/j.ebiom.2025.105600_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1080\/15563650801953182","article-title":"Severe iatrogenic bismuth poisoning with bismuth iodoform paraffin paste treated with DMPS chelation","volume":"46","author":"Ovaska","year":"2008","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ebiom.2025.105600_bib30","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1136\/jnnp.57.9.1133","article-title":"Acute arsenic poisoning: absence of polyneuropathy after treatment with 2,3-dimercaptopropanesulphonate (DMPS)","volume":"57","author":"Moore","year":"1994","journal-title":"J\u00a0Neurol Neurosurg Psychiatry"},{"key":"10.1016\/j.ebiom.2025.105600_bib31","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/S0022-3565(25)38988-3","article-title":"Determination and metabolism of dithiol chelating agents XVI: pharmacokinetics of 2,3-dimercapto-1-propanesulfonate after intravenous administration to human volunteers","volume":"268","author":"Hurlbut","year":"1994","journal-title":"J\u00a0Pharmacol Exp Therapeut"},{"key":"10.1016\/j.ebiom.2025.105600_bib32","series-title":"National institutes of health, national Institute of allergy and infectious diseases, division\u00a0of\u00a0AIDS. Division of AIDS (DAIDS) table for grading the severity of adult\u00a0and pediatric adverse events, Corrected Version 2.1","year":"2017"},{"key":"10.1016\/j.ebiom.2025.105600_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.12688\/wellcomeopenres.17682.1","article-title":"TRUE-1: trial of repurposed unithiol for snakebite envenoming phase 1 (safety, tolerability, pharmacokinetics and pharmacodynamics in healthy Kenyan adults)","volume":"7","author":"Abouyannis","year":"2022","journal-title":"Wellcome Open Res"},{"key":"10.1016\/j.ebiom.2025.105600_bib34","article-title":"Enhancing reporting quality and impact of early phase dose-finding clinical trials: CONSORT Dose-finding Extension (CONSORT-DEFINE) guidance","volume":"383","author":"Yap","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/j.ebiom.2025.105600_bib35","series-title":"R: a language and environment for statistical computing","year":"2023"},{"key":"10.1016\/j.ebiom.2025.105600_bib36","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1111\/j.1365-3156.2007.01924.x","article-title":"Healthcare-seeking behaviour and use of traditional healers after snakebite in Hlabisa sub-district, KwaZulu Natal","volume":"12","author":"Sloan","year":"2007","journal-title":"Trop Med Int Health"},{"key":"10.1016\/j.ebiom.2025.105600_bib37","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.toxicon.2013.09.003","article-title":"Hemostasis dynamics during coagulopathy resulting from Echis envenomation","volume":"76","author":"Mion","year":"2013","journal-title":"Toxicon"},{"key":"10.1016\/j.ebiom.2025.105600_bib38","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0132237","article-title":"Older age and time to medical assistance are associated with severity and mortality of snakebites in the Brazilian amazon: a case-control study","volume":"10","author":"Feitosa","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.ebiom.2025.105600_bib39","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1080\/15563650.2016.1250903","article-title":"Australian taipan (Oxyuranus spp.) envenoming: clinical effects and potential benefits of early antivenom therapy\u2014Australian Snakebite Project (ASP-25)","volume":"55","author":"Johnston","year":"2017","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ebiom.2025.105600_bib40","first-page":"27","article-title":"A\u00a0simple practice guide for dose conversion between animals and human","volume":"7","author":"Nair","year":"2016","journal-title":"J\u00a0Basic Clin Pharm"},{"key":"10.1016\/j.ebiom.2025.105600_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.toxcx.2022.100118","article-title":"In\u00a0vitro and in\u00a0vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus","volume":"14","author":"Menzies","year":"2022","journal-title":"Toxicon X"},{"key":"10.1016\/j.ebiom.2025.105600_bib42","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1328950","article-title":"Snakebite drug discovery: high-throughput screening to identify novel snake venom metalloproteinase toxin inhibitors","volume":"14","author":"Clare","year":"2024","journal-title":"Front Pharmacol"},{"key":"10.1016\/j.ebiom.2025.105600_bib43","doi-asserted-by":"crossref","first-page":"6094","DOI":"10.1038\/s41467-020-19981-6","article-title":"A\u00a0therapeutic combination of two small molecule toxin inhibitors provides broad preclinical efficacy against viper snakebite","volume":"11","author":"Albulescu","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/j.ebiom.2025.105600_bib44","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.bbapap.2011.04.009","article-title":"Snake venom metalloproteinases: structure, function and relevance to the mammalian ADAM\/ADAMTS family proteins","volume":"1824","author":"Takeda","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/j.ebiom.2025.105600_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.jinorgbio.2020.111319","article-title":"Structural analysis of metal chelation of the metalloproteinase thermolysin by 1,10-phenanthroline","volume":"215","author":"Nam","year":"2021","journal-title":"J\u00a0Inorg Biochem"},{"key":"10.1016\/j.ebiom.2025.105600_bib46","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/BF00296388","article-title":"Distribution and excretion of the mercury chelating agent sodium 2,3-dimercaptopropane-1-sulfonate in the rat","volume":"39","author":"Gabard","year":"1978","journal-title":"Arch Toxicol"},{"key":"10.1016\/j.ebiom.2025.105600_bib47","doi-asserted-by":"crossref","first-page":"493","DOI":"10.3109\/15563659209017937","article-title":"BAL, EDTA, DMSA and DMPS in the treatment of lead poisoning in children","volume":"30","author":"Chisolm","year":"1992","journal-title":"J\u00a0Toxicol Clin Toxicol"},{"key":"10.1016\/j.ebiom.2025.105600_bib48","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1080\/15563650701779687","article-title":"Stevens-Johnson syndrome in a child with chronic mercury exposure and 2,3-dimercaptopropane-1-sulfonate (DMPS) therapy","volume":"46","author":"Van der Linde","year":"2008","journal-title":"Clin Toxicol"},{"key":"10.1016\/j.ebiom.2025.105600_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000767","article-title":"Randomised controlled double-blind non-inferiority trial of two antivenoms for saw-scaled or carpet viper (Echis ocellatus) envenoming in Nigeria","volume":"4","author":"Abubakar","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib50","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0006068","article-title":"Safety and efficacy of a freeze-dried trivalent antivenom for snakebites in the Brazilian Amazon: an open randomized controlled phase IIb clinical trial","volume":"11","author":"Mendon\u00e7a-da-Silva","year":"2017","journal-title":"PLoS Neglected Trop Dis"},{"key":"10.1016\/j.ebiom.2025.105600_bib51","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0090-9556(25)06913-2","article-title":"In\u00a0vivo renal tubular secretion and metabolism of the disulfide of 2,3-dimercaptopropane-1-sulfonate","volume":"16","author":"Stewart","year":"1988","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/j.ebiom.2025.105600_bib52","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.tips.2021.02.005","article-title":"Small molecule drug discovery for neglected tropical snakebite","volume":"42","author":"Clare","year":"2021","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.ebiom.2025.105600_bib53","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/0041-0101(64)90014-5","article-title":"The chemical modification of necrogenic and proteolytic activities of venom and the use of EDTA to produce Agkistrodon piscivorus, a venom toxoid","volume":"2","author":"Goucher","year":"1964","journal-title":"Toxicon"},{"key":"10.1016\/j.ebiom.2025.105600_bib55","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/S2214-109X(22)00479-X","article-title":"A\u00a0global core outcome measurement set for snakebite clinical trials","volume":"11","author":"Abouyannis","year":"2023","journal-title":"Lancet Global Health"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000441?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396425000441?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T16:18:41Z","timestamp":1762618721000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396425000441"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":52,"alternative-id":["S2352396425000441"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105600","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development of an oral regimen of unithiol for the treatment of snakebite envenoming: a phase 1 open-label dose-escalation safety trial and pharmacokinetic analysis in healthy Kenyan adults","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2025.105600","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"105600"}}